Received 18.12.2022
DOI: 10.35556/idr-2023-2(103)64-70
Orthodontic treatment practical considerations during general somatic pathology correction with drugs that slow down bone resorption
Tsvetkova M.A., Kovalenko A.U.
GAUZ “Dental clinic №50 DZM”
Russia, 107140, Moscow, Verkhnyaya Krasnoselskaya St., 19

E-mail address: tsvetkova-orthodont@inbox.ru

Summary
According to the literature, more than 60% of orthodontic patients take certain medications and/or nutritional supplements on regular basis. To improve the efficiency and quality of treatment, based on systematic reviews and meta-analyses, an orthodontic treatment algorithm has been developed for patients taking bisphosphonates, drugs for the treatment of diabetes (except thiazolidinediones and SGLT-2 inhibitors), antihypertensives, antihistamines, statins, NSAIDs, estrogen-containing drugs, tetracycline, interferon- (deposit certificate No. 2080699). Algorithm helps orthodontist to make correct treatment plan, select appropriate orthodontic appliance activation regime, choose additional diagnostic procedures and consultations with doctors of other medical specialities.

Keywords: anamnesis, orthodontic treatment, drugs.

For citation: Tsvetkova M.A., Kovalenko A.U. Orthodontic treatment practical considerations during general somatic pathology correction with drugs that slow down bone resorption. Stomatology for All / Int. Dental Review. 2023, no.2(103): 64-70 (In Russian). doi: 10.35556/idr-2023-2(103)64-70

References
1. Каганова О.С., Олесов Е.Е., Тихонов В.Э., Рева В.В., Кащенко П.В., Микрюков В.В. Ортодонтический статус у детей в период сменного прикуса. Российский стоматологический журнал. 2018, 22(4): 203—205. doi: 10.18821/1728-2802-2018-22-4-203-205
Kaganova O.S., Olesov E.E., Tihonov V.E., Reva V.V., Kachenko P.V., Mikrukov V.V. Orthodontic status in children during the period of removable bite. Russian journal of dentistry. 2018, 22(4): 203—205 (In Russian). doi: 10.18821/1728-2802-2018-22-4-203-205
2. Косюга С.Ю., Агутина А.С., Беляков С.А. Анализ функциональных расстройств зубочелюстной системы у школьников. Российский стоматологический журнал. 2016, 20(2): 88—90. doi: 10.18821/1728-28022016;20(2):88-90
Kosuga S.U., Agutina A.S., Belyakov S.A. Dental system functional disorders analysis in schoolchildren. Russian Dental Journal. 2016, 20(2): 88—90 (In Russian). doi: 10.18821/1728-28022016;20(2):88-90
3. Chauhan N., Parikh T., Patel S., Shah A., Pandya P., Shah K. Diabetes mellitus, a myth in orthodontics? International Journal of Preventive and Clinical Dental Research. 2018, 5(3): 24—28. doi: 10.4103/INPC.INPC_3_18
4. Сохов С.Т., Цветкова М.А. Первичная диагностика и планирование лечения у пациентов с сопутствующей патологией и лекарственной терапией. Медицинские новости Грузии. 2021, №7—8: 79—83.
Sohov S., Tsvetkova M. Primary diagnostics and orthodontic treatment planning for patients on medical regimen for concomitant pathologies. Georgian Medical News. 2021, no.7—8: 79—83 (in Russian).
5. Faruqui S., Fida M., Shaikh A. Factors affecting treatment duration — a dilemma in orthodontics. J Ayub Med Coll Abbottabad. 2018, 30(1): 16—21.
6. Gilbert M.P., Pratley R.E. The impact of diabetes and diabetes medications on bone health. Endocr Rev. 2015, 36(2): 194—213. doi: 10.1210/er.2012-1042
7. Venkataramana V., Chidambaram S., Reddy B.V., Goud E.S.S., Arafath M., Krishnan S. Impact of bisphosphonate on orthodontic tooth movement and osteoclastic count: an animal study. Journal of International Oral Health. 2014, 6(2): 1—8.
8. Lotwala R.B., Greenlee G.M., Ott S.M., Hall S.H., Huang G.J. Bisphosphonates as a risk factor for adverse orthodontic outcomes: a retrospective cohort study. Am J Orthod Dentofacial Orthop. 2012, 142(5): 625—634. doi: 10.1016/j.ajodo.2012.05.019
9. Zahrowski J.J. Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis. Am J Orthod Dentofacial Orthop. 2009, 135(3): 361—374. doi: 10.1016/j.ajodo.2008.08.017
10. Аксамит Л.А., Цветкова А.А. Заболевания слизистой оболочки рта. Связь с общей патологией. Диагностика. М.: МЕДпресс-Информ, 2016, 288 с.
Aksamit L.A., Tsvetkova A.A. Oral mucosa diseases. Relationship with general pathology. Diagnostics. Moscow: Medpress-Inform, 2016, 288 p. (In Russian).
11. Celebi A. A., Demirer S., Catalbas B., Arikan S. Effect of ovarian activity on orthodontic tooth movement and gingival crevicular fluid levels of interleukin-1 and prostaglandin E(2) in cats. Angle Orthodontist. 2013, 83(1): 70—75. doi: 10.2319/012912-78.1
12. Gradosova I., Zivna H., Palicka V., Hubena S., Svejkovska K., Zivny P. Protective effect of atorvastatin on bone tissue in orchidectomised male albino Wistar rats. Eur J Pharmacol. 2012, 679(1—3): 144—150. doi: 10.1016/j.ejphar.2012.01.014
13. Tsartsalis A.N., Dokos C., Kaiafa G.D., Tsartsalis D.N., Kattamis A., Hatzitolios A.I., et. al. Statins, bone formation and osteoporosis: hope or hype? Hormones. 2012, 11(2): 126—139. doi: 10.14310/horm.2002.1339
14. Esfahani N.E., Sadeghian S., Razavi M., Minaiyan M., Afsari E. The effects of simvastatin on bone remodeling, tooth movement and root resorption in orthodontic treatments. Biomedical and Pharmacology Journal. 2013, 6(2): 271—278. doi: 10.13005/bpj/414
15. Marcial B.L., Sousa S.F., Barbosa I.L., Dos Santos H.F., Ramos M.J. Chemically modified tetracyclines as inhibitors of MMP-2 matrix metalloproteinase: a molecular and structural study. J Phys. Chem. B. 2012, 116(46): 13644—13654. doi: 10.1021/jp3079748
16. Baysal A., Uysal T., Ozdamar S., Kurt B., Kurt G., Gunhan O. Comparisons of the effects of systemic administration of l-thyroxine and doxycycline on orthodontically induced root resorption in rats. European Journal of Orthodontics. 2010, 32(5): 496—504. doi: 10.1093/ejo/cjp124
17. Kohara H., Kitaura H., Yoshimatsu M., Fujimura Y., Morita Y., Eguchi T., et al. Inhibitory effect of interferon- on experimental tooth movement in mice. J Interferon Cytokine Res. 2012, 32(9): 426—431. doi: 10.1089/jir.2011.0124
18. Hashemi S.M., Otoofi A., Badiee M.R., Abdolazimi F. Orthodontic tooth movement and root resorption after different doses of Celecoxib drug treatment in Rats. J Dent Sch. 2012, 29(4): 230—241.
19. Meh A., Sprogar S., Vaupotic T., Cor A., Drevensek G., Marc J., et. al. Effect of cetirizine, a histamine (H(1)) receptor antagonist, on bone modeling during orthodontic tooth movement in rats. American Journal of Orthodontics and Dentofacial Orthopedics. 2011, 139(4): e323—e329. doi: 10.1016/j.ajodo.2009.11.013
20. Aghili H., Ardekani M.D., Meybodi S.A.R.F., Toodehzaeim M.H., Modaresi J., Mansouri R., et. al. The effect of ovalbumin on orthodontic induced root resorption. Dent Res J (Isfahan). 2013, 10(5): 630—635.
21. Rodrigues W.F., Madeira M.F., da Silva T.A., Clemente-Napimoga J.T., Miguel C.B., Diasda Silva V.J., et. al. Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation. British Journal of Pharmacology. 2012, 165(7): 2140—2151. doi: 10.1111/j.1476-5381.2011.01686.x
22. De Oliveira E.L., Freitas F.F., de Macedo C.G., Clemente-Napimoga J.T., Silva M.B.F., Manhaes-Jr L.R.C., et. al. Low dose propranolol decreases orthodontic movement. Archives of Oral Biology. 2014, 59(10): 1094—1100. doi: 10.1016/j.archoralbio.2014.06.006
23. Moura A.P., Montalvany-Antonucci C.C., de Albuquerque Taddei S.R., Queiroz-Junior C. M., Biguetti C.C., Garlet G.P. et. al. Effects of angiotensin II type I receptor blocker losartan on orthodontic tooth movement. American Journal of Orthodontics and Dentofacial Orthopedics. 2016, 149(3): 358—365. doi: 10.1016/j.ajodo.2015.09.019
24. Salazar M., Hernandes L., Ramos A.L., de Oliveira Salazar B., Micheletti K.R., Paranhos L.R. et. al. Effect of alendronate sodium on tooth movement in ovariectomized rats. Archives of Oral Biology. 2015, 60(5): 776—781. doi: 10.1016/j.archoralbio.2015.02.003
25. Seifi M., Asefi S., Hatamifard G., Lotfi A. Effect of local injection of Zolena, zoledronic acid made in Iran, on orthodontic tooth movement and root and bone resorption in rats. Journal of Dental Research, Dental Clinics, Dental Prospects. 2017, 11(4): 257—264. doi: 10.15171/joddd.2017.045
26. Lecka-Czernik B. Diabetes, bone and glucose-lowering agents: basic biology. Diabetologia. 2017, 60(7): 1163—1169. doi: 10.1007/s00125-017-4269-4